TheraRadar

Pharma Intelligence, Simplified

← All Targets

Antithrombin III

14 drugs
Cardiovascular
14
Approved Drugs
6
Companies
10
Indications
1
Therapeutic Areas
Unlock Full Target Intelligence PRO
Competitive landscape by company (6 companies)
All 14 approved drugs
Therapeutic area breakdown
Full indication list (10 indications)
Patent cliff analysis
Clinical trials pipeline
Upgrade to Pro
Starting at $99/mo

Drugs by Company

Pfizer 6 drugs
Fresenius Kabi 3 drugs
Baxter 2 drugs

By Therapeutic Area

Cardiovascular 10 drugs
Other 4 drugs